Justin, S.; Rutz, J.; Maxeiner, S.; Chun, F.K.-H.; Juengel, E.; Blaheta, R.A.
Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells. Int. J. Mol. Sci. 2020, 21, 4026.
https://doi.org/10.3390/ijms21114026
AMA Style
Justin S, Rutz J, Maxeiner S, Chun FK-H, Juengel E, Blaheta RA.
Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells. International Journal of Molecular Sciences. 2020; 21(11):4026.
https://doi.org/10.3390/ijms21114026
Chicago/Turabian Style
Justin, Saira, Jochen Rutz, Sebastian Maxeiner, Felix K.-H. Chun, Eva Juengel, and Roman A. Blaheta.
2020. "Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells" International Journal of Molecular Sciences 21, no. 11: 4026.
https://doi.org/10.3390/ijms21114026
APA Style
Justin, S., Rutz, J., Maxeiner, S., Chun, F. K.-H., Juengel, E., & Blaheta, R. A.
(2020). Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells. International Journal of Molecular Sciences, 21(11), 4026.
https://doi.org/10.3390/ijms21114026